Digital Health Industry in Europe, Growth and Demand

Introduction: Europe's Digital Health Industry Enters an Investment Supercycle

The Europe Digital Health Industry has become the continent's principal answer to a demographic and fiscal problem that hospitals alone cannot solve: ageing populations, rising chronic-disease burdens and persistent clinical staff shortages, set against public health budgets that cannot expand at the same pace as demand. According to IMARC Group, the market reached USD 130.37 Billion in 2025, rose to USD 143.78 Billion in 2026, and is projected to reach USD 314.32 Billion by 2034, expanding at a CAGR of 10.27% (2026–2034). Regulation is now the primary accelerant rather than an afterthought. Regulation (EU) 2025/327 establishing the European Health Data Space (EHDS), published in the Official Journal of the European Union on 5 March 2025 and in force from 25 March 2025, obliges every Member State to designate a digital health authority and a national contact point by 26 March 2027, and requires electronic health record systems placed on the EU market to conform to a common European exchange format.

Demand-side drivers are structural rather than cyclical. National rollouts are already at scale. Germany's Federal Ministry of Health and the national digital agency gematik launched the "ePA für alle" pilot on 15 January 2025 across Franken, Hamburg and parts of North Rhine-Westphalia, with roughly 300 medical practices, pharmacies and hospitals participating, while statutory insurers had created more than 70 Million electronic patient records by mid-February 2025 under an opt-out model. In Italy, PNRR Mission 6 "Salute" commits EUR 15.6 Billion, split between EUR 7.75 Billion for proximity care, structures and telemedicine and EUR 7.87 Billion for innovation, research and digitalisation of the national health service including EUR 1.3 Billion for the Fascicolo Sanitario Elettronico (FSE) and EUR 1.5 Billion for telemedicine. On the supply side, cloud-native record platforms, AI diagnostic suites, remote-monitoring hardware and digital therapeutics pipelines are all being rebuilt for a market that must satisfy a national reimbursement authority and a European interoperability regime simultaneously.

At the segmentation level, telehealth, medical wearables, EMR/EHR systems, medical apps and healthcare analytics form the product architecture of the market, increasingly delivered as software rather than as stand-alone hardware or one-off services the compositional shift that is lifting gross margins and drawing investor capital. Regionally the market remains concentrated: Germany, France and the United Kingdom are the largest national markets, the Nordics function as the continent's proving ground for interoperable records and remote care, and Italy and Spain are scaling fastest off recovery-fund investment. The defining theme of 2026 is the collision of two regulatory clocks EHDS interoperability deadlines and EU AI Act obligations which together force vendors to demonstrate data governance and clinical evidence at the same moment they scale.

This blog examines the Europe Digital Health Industry's size and segments, recent announcements, trends shaping 2026, geographic hotspots, competitive landscape, policy environment, forecast through 2034, and the opportunities available to manufacturers, investors, technology providers and distributors.

Key Takeaways

• The Europe Digital Health Industry was valued at USD 130.37 Billion in 2025, rose to USD 143.78 Billion in 2026, and is forecast to reach USD 314.32 Billion by 2034, growing at a CAGR of 10.27% (2026–2034).
• Telehealth and remote-care platforms form the highest-visibility demand layer, followed by medical wearables, EMR/EHR systems, medical apps and healthcare analytics, while software delivery is the fastest-growing component as licensing and subscription models displace one-off hardware purchases.
• Germany, France and the United Kingdom constitute the largest national markets and the deepest pools of venture and public capital, with the Nordics leading on interoperable records and Italy and Spain scaling fastest on EU recovery-fund investment.
• Regulation (EU) 2025/327 on the European Health Data Space was published on 5 March 2025 and entered into force on 25 March 2025, requiring Member States to appoint digital health authorities and national contact points by 26 March 2027, the single largest structural driver in the market.
• Germany's "ePA für alle" pilot opened on 15 January 2025 with roughly 300 sites and more than 70 Million electronic patient records created within a month, while Italy's PNRR Mission 6 allocates EUR 15.6 Billion, including EUR 1.3 Billion for the FSE and EUR 1.5 Billion for telemedicine.

Europe Digital Health Market Size, Share & Growth Outlook

According to IMARC Group, the Europe Digital Health Market reached USD 130.37 Billion in 2025 and is projected to reach USD 314.32 Billion by 2034, at a CAGR of 10.27% during 2026–2034, with an interim value of USD 143.78 Billion in 2026. Growth is broad-based across product types, components and countries, but the fastest expansion is concentrated in telehealth and remote monitoring, AI-assisted clinical software and interoperable record infrastructure that satisfies the EHDS regime. The leading segments are:

• By Type: Telehealth platforms anchor the largest and most visible share of the Type segment, spanning video consultation, asynchronous review and virtual ward management that national health services now fund directly. Medical wearables continuous glucose monitors, cardiac patch monitors, connected spirometers and consumer-grade trackers feeding clinical workflows and EMR/EHR systems form the second and third major groupings, while medical apps and healthcare analytics are the fastest-growing sub-segments as AI-assisted triage, coding and population-health tooling move from pilot to procurement.
• By Component: Software accounts for the largest and fastest-growing component share as health systems migrate from perpetual licences to subscription, per-seat and plug-in licensing models, which lowers total cost of ownership for cash-constrained hospitals and produces recurring revenue for vendors. Services integration, interoperability engineering, clinical change management and managed hosting follow closely, while Hardware remains substantial but structurally slower-growing as monitoring devices commoditise and increasingly bundle into software contracts.
• By Region: Germany, France and the United Kingdom jointly dominate the market on the strength of national digital mandates, mature reimbursement pathways and the deepest concentration of health-tech venture capital. The Nordics follow as the most advanced adopters of interoperable records and hospital-at-home models, while Italy and Spain are the fastest-growing large markets as PNRR and equivalent recovery-fund spending converts into deployed infrastructure, and Central and Eastern Europe represents the longest-range headroom as EU structural funds reach national health systems.

Recent News & Mega Announcements

Recent developments in the Europe Digital Health Industry include significant announcements, investments and partnerships:

• In March 2025, the European Parliament and the Council published Regulation (EU) 2025/327 on the European Health Data Space in the Official Journal of the European Union, with entry into force on 25 March 2025 and phased application beginning 26 March 2029 for priority data categories, creating the first single legal framework for cross-border health data access and reuse across the EU and the European Economic Area.
• In January 2025, Germany's Federal Ministry of Health (BMG) and the national digital agency gematik began the pilot phase of the "ePA für alle" electronic patient record in the model regions of Franken, Hamburg and parts of North Rhine-Westphalia, involving roughly 300 medical practices, dental practices, pharmacies and hospitals, ahead of a nationwide rollout in which all care providers become obliged to use the record.
• In October 2024, Agenas, the Italian national agency for regional health services, presented the National Telemedicine Platform (PNT), designed to interoperate with the FSE 2.0 and Italy's Health Data Ecosystem and funded through the EUR 1.5 Billion telemedicine line of PNRR Mission 6, which targets telemedicine assistance for at least 300,000 people across the national territory.
• In 2024, London-based Doccla raised GBP 35 Million to scale its remote patient monitoring and virtual ward platform across UK and European health systems, at the same time as German hospitals received an additional government allocation of EUR 300 Million for electronic health record and cybersecurity upgrades.
• In November 2023, NHS England awarded a seven-year Federated Data Platform contract worth GBP 330 Million, placing secure, nationally governed data infrastructure at the centre of English health service planning and creating a reusable analytics layer on which clinical software vendors now build.

Industry Trends Shaping 2026

Three trends are shaping the Europe Digital Health Industry in 2026:

1. EHDS Interoperability Becomes a Product Requirement

The EHDS Regulation (EU) 2025/327, published on 5 March 2025 and in force from 25 March 2025, converts interoperability from a competitive advantage into a market-access condition. Member States must designate digital health authorities and national contact points by 26 March 2027; patients gain rights over patient summaries, electronic prescriptions and electronic dispensations from 26 March 2029, and over medical imaging, laboratory results and discharge reports from 26 March 2031. Any EHR system placed on the EU market after those dates must meet the common European exchange format, which is forcing a replacement cycle among legacy hospital record systems that cannot be retrofitted.

2. AI Regulation Meets Clinical Evidence

Regulation (EU) 2024/1689 the EU AI Act entered into force on 1 August 2024, with prohibited practices applicable from 2 February 2025 and obligations for high-risk systems from 2 August 2026. Most clinical decision-support and diagnostic AI is simultaneously a medical device under Regulation (EU) 2017/745 (MDR), so vendors must maintain technical documentation, human-oversight design and post-market surveillance for two separate regimes. The practical consequence is consolidation: capital and hospital procurement are migrating towards suppliers that can carry that regulatory overhead, while point-solution developers increasingly sell into platforms rather than to hospitals directly.

3. Care Moves From Hospital to Home

The centre of gravity of European care delivery is shifting out of the hospital. Italy's PNRR Mission 6 devotes EUR 1.5 Billion to telemedicine and requires at least 300,000 people to be assisted through telemedicine tools nationally, with the National Telemedicine Platform interoperating with the FSE 2.0 and the Health Data Ecosystem. Germany's national record programme passed 70 Million created electronic patient records within a month of its 15 January 2025 pilot start. Remote monitoring, virtual wards, connected diagnostics and digital-first chronic care pathways are the fastest-growing commercial layer of the market.

Geographic Hotspots

Germany is the largest and most institutionally committed national market in the Europe Digital Health Industry. The Digital Act (DigiG) provided the legal architecture for the "ePA für alle" national record, whose pilot phase began on 15 January 2025 across Franken, Hamburg and parts of North Rhine-Westphalia and had produced more than 70 Million electronic patient records within roughly a month. Germany also operates continental Europe's most developed reimbursement pathway for prescribed digital health applications, and its hospital sector has received dedicated modernisation funding for record systems and cybersecurity, making it the reference market for vendors selling into statutory insurers rather than directly to consumers.

France and the United Kingdom form the second great investment cluster. France combines a national health data platform, a large public digital-health investment envelope and a statutory insurance system that is increasingly willing to fund remote monitoring and teleconsultation, which is why Paris-based platforms have been able to build multi-country businesses on the back of domestic reimbursement. The United Kingdom contributes the deepest venture-capital pool in European health technology and the most aggressive data-infrastructure programme, anchored by the Federated Data Platform contract worth GBP 330 Million awarded by NHS England in November 2023, which gives clinical software developers a governed analytics layer to build on.

The Nordics remain the continent's proving ground. Denmark, Sweden, Finland and Norway operate near-universal electronic record coverage, mature hospital-at-home services and procurement cultures that reward interoperability over brand, which makes them the first market where cross-border EHDS use cases are likely to become routine rather than experimental. Italy and Spain are the fastest-growing large markets: Italy's PNRR Mission 6 commits EUR 15.6 Billion, including EUR 1.3 Billion for the Fascicolo Sanitario Elettronico and EUR 1.5 Billion for telemedicine, while Spain has built a national digital health strategy around the public health system and the EHDS roadmap.

Central and Eastern Europe represents the longest-range opportunity. These markets are younger in infrastructure terms, which means less legacy to displace, and they are beneficiaries of EU structural and recovery funding directed at national health digitalisation. Adoption there will be shaped less by consumer demand than by the pace at which national authorities can designate EHDS digital health authorities and connect to the MyHealth@EU cross-border infrastructure.

Competitive Landscape & Key Players' Strategies

Competitive activity is intensifying as leading players expand across the Europe Digital Health Industry:

• Siemens Healthineers AG: Anchors its enterprise software portfolio on the teamplay Digital Health Platform and the AI-Rad Companion clinical decision-support suite, alongside syngo Carbon and fleet-management tooling, positioning itself as the imaging-and-workflow layer of the digital hospital and a natural partner for national health services seeking EHDS-aligned interoperability.
• Koninklijke Philips N.V.: Operates a broad Connected Care franchise spanning telehealth, remote patient monitoring, sleep and respiratory care and enterprise informatics, with HealthSuite, IntelliSpace and IntelliVue platforms deployed across European hospitals, and a strategic focus on hospital-to-home continuity and cardiac remote monitoring in Germany and France.
• Medtronic plc: Combines the largest installed base of implantable and monitoring devices in Europe with a growing software and data-services layer, using device-generated clinical data as the entry point into remote monitoring contracts with national health systems and private hospital groups.
• Oracle (Oracle Health): Inherited the Cerner hospital information system base through its acquisition of Cerner Corporation and is converting that footprint into cloud-hosted record infrastructure, targeting the replacement cycle created by EHDS interoperability requirements across European hospital groups.
• Epic Systems Corporation: Europe's most significant non-European record-system competitor, expanding through large academic hospital and regional health authority deployments and differentiating on mature interoperability, population-health analytics and research-grade data feeds that align with EHDS secondary-use provisions.

With the top tier of vendors controlling a minority of total revenue, the European market remains structurally fragmented at the application layer. What wins is a combination of regulatory maturity across GDPR, the AI Act and MDR, demonstrable EHDS interoperability, documented clinical and economic outcomes, and the ability to sell the same product line to multiple national reimbursement systems.

Policy & Regulatory Landscape

The Europe Digital Health Industry operates within a supportive and unusually prescriptive policy and regulatory framework:

• European Health Data Space Regulation (EU) 2025/327: Published on 5 March 2025 and in force from 25 March 2025, it creates a common framework for primary use giving patients free access to their electronic health data and clinicians access to cross-border records through MyHealth@EU and for secondary use, allowing controlled access to anonymised or pseudonymised data for research, innovation and health policy. Member States must designate digital health authorities and national contact points by 26 March 2027, with priority data categories applicable from 26 March 2029 and the remainder from 26 March 2031.
• General Data Protection Regulation (EU) 2016/679): Governs the processing of health data as a special category of personal data, imposing lawful-basis, data-minimisation, consent and security obligations that shaped the architecture of every European digital health product and continue to discipline AI training data strategies.
• EU AI Act (Regulation (EU) 2024/1689): Entered into force on 1 August 2024, with prohibitions applicable from 2 February 2025 and high-risk obligations from 2 August 2026, classifying most clinical AI as high-risk and imposing risk management, data governance, transparency, human oversight and post-market monitoring duties on providers.
• Medical Device Regulation (EU) 2017/745 and In Vitro Diagnostic Regulation (EU) 2017/746: Determine which software qualifies as a medical device and set the conformity-assessment route, clinical evaluation and post-market surveillance requirements that digital health vendors must satisfy before commercial deployment.
• Data Act (EU) 2023/2854 and Data Governance Act (EU) 2022/868: Broaden rights of access to and portability of connected-product data, including data generated by medical devices and wellness applications, which directly affects the commercial models of wearables and remote-monitoring suppliers.
• NIS2 Directive (EU) 2022/2555 and Cyber Resilience Act (EU) 2024/2847: Bring healthcare providers and critical digital suppliers into a common cybersecurity and product-security regime, raising the security baseline for connected medical software and adding compliance cost to every internet-connected health product sold in the EU.
• German Digital Act (DigiG), the national ePA and the DiGA pathway: Provide the legal basis for the "ePA für alle" opt-out record whose pilot began on 15 January 2025 and for statutory reimbursement of prescribed digital health applications listed in the national directory, making Germany the template other Member States study.
• Italy's PNRR Mission 6 "Salute": Commits EUR 15.6 Billion, including EUR 1.3 Billion for the Fascicolo Sanitario Elettronico, EUR 1.5 Billion for telemedicine and dedicated funding for digitalising around 280 hospital facilities, using centralised framework agreements to accelerate procurement.

Challenges & Risks

Key challenges and risks include:

• National Reimbursement Fragmentation: Despite a single EU data framework, reimbursement for teleconsultation, remote monitoring and digital therapeutics remains a national competence, so every market requires a separate evidence dossier, pricing negotiation and coding pathway the single largest cost of scaling in Europe.
• Data Privacy, Security and Public Trust: Health data is a special category under GDPR, and high-profile security concerns around national record programmes have already delayed rollouts and driven opt-out rates; cybersecurity incidents in hospital networks carry both regulatory and reputational consequences.
• Clinical Evidence and HTA Scrutiny: Payers increasingly demand randomised or real-world evidence of clinical and economic benefit before funding digital tools, and the new European health technology assessment framework adds further evidentiary requirements for products that fall within its scope.
• Interoperability Debt in Legacy Systems: Large parts of the European hospital estate still run record systems and departmental software that cannot natively produce the common European exchange format, making migration cost not ambition the binding constraint on EHDS compliance dates.
• Workforce Shortages and Change Fatigue: Clinical staff shortages mean digital tools are judged on whether they save time rather than whether they add functionality, and poorly implemented rollouts quickly lose clinician support, which remains the most common cause of stalled deployments.
• Funding Volatility: A material share of recent growth is financed by EU recovery and structural funds with fixed end dates, creating cliff risk for national programmes that have not yet secured recurrent budget lines for maintenance, hosting and licensing.

Forecast 2026–2034

IMARC Group projects the Europe Digital Health Industry to expand from USD 130.37 Billion in 2025 to USD 314.32 Billion by 2034, at a CAGR of 10.27% (2026–2034), with the market already reaching USD 143.78 Billion in 2026.

That trajectory reflects a market in which the initial disruption of emergency-era teleconsultation and pilot-stage records has given way to a more mature phase in which regulatory compliance, clinical evidence and national reimbursement determine competitive position. Telehealth and remote-care platforms will continue to grow fastest as permanent funding pathways replace pandemic-era exceptions, while medical wearables and remote monitoring expand with chronic-disease management and hospital-at-home models. Software will continue to take share from hardware as licensing models mature and as AI-assisted clinical tooling becomes a standard layer rather than a stand-alone purchase. The EHDS implementation milestones of 2027, 2029 and 2031 act as a schedule of forced investment: member states, hospital groups and record-system vendors must deliver interoperable infrastructure before those dates, converting a policy obligation into a decade-long procurement cycle. Germany, France and the United Kingdom will retain combined leadership of regional revenue, while Italy, Spain and Central and Eastern Europe deliver the highest growth rates off recovery and structural funding. Demographic pressure, clinical labour scarcity and the cost of ageing will ensure that double-digit expansion continues through the end of the forecast period.

Opportunities for Stakeholders

• Manufacturers / Suppliers: The EHDS interoperability deadlines of 2027, 2029 and 2031 create a forced replacement cycle for record systems, departmental software and connected devices that cannot produce the common European exchange format. Suppliers that certify conformity early and that can serve multiple national reimbursement regimes from one product line will capture procurement ahead of the compliance cliff.
• Investors / Lenders: The market's expansion from USD 130.37 Billion in 2025 to USD 314.32 Billion by 2034, at a CAGR of 10.27% offers a policy-backed, demand-anchored thesis. Highest-conviction opportunities lie in remote monitoring and virtual-ward operators with published outcome data, clinical AI vendors that hold both MDR and AI Act documentation, and interoperability and cybersecurity specialists whose services every hospital group must buy to reach EHDS compliance.
• Technology Providers: Demand is rising for interoperability engines, FHIR-based data pipelines, secure processing environments for secondary use, clinical decision support with audit trails, and privacy-preserving analytics capable of operating inside GDPR and AI Act constraints. Providers that position their products as EHDS-ready infrastructure rather than as point applications will find a materially larger addressable market.
• Distributors / End Users: Health systems, statutory insurers and community care providers gain most by treating digital procurement as a multi-year programme aligned to EHDS milestones rather than as discrete IT purchases. Buying interoperable, subscription-based platforms with published clinical evidence reduces migration risk, and aggregated regional purchasing as demonstrated by Italy's centralised framework agreements lowers unit cost while shortening deployment time.
• Digital Therapeutics and Consumer Diagnostics Developers: Reimbursement pathways such as Germany's prescribed digital applications route give evidence-based digital therapeutics a funded route to patients, while consumer diagnostics and wearables create a lower-friction entry point into clinical workflows when their data can be surfaced into national records. Building for the strictest market first remains the most efficient route to pan-European scale.

Conclusion: Regulated Interoperability Becomes Europe's Growth Engine

The Europe Digital Health Industry, valued at USD 130.37 Billion in 2025 and projected to reach USD 314.32 Billion by 2034, at a CAGR of 10.27% (2026–2034), is being reshaped by three forces operating at once: the European Health Data Space regulation, which from March 2025 made interoperable records a legal requirement rather than a vendor feature; national digital mandates and recovery-funded investment, exemplified by Germany's "ePA für alle" and Italy's EUR 15.6 Billion PNRR Mission 6; and the steady migration of care from hospital wards into homes and communities.

The obstacles are real fragmented national reimbursement, privacy and security exposure, demanding clinical evidence thresholds, legacy interoperability debt, clinical workforce shortages and the funding cliff that follows recovery-money programmes. Yet each is navigable by vendors that build for EHDS interoperability first, carry MDR and AI Act compliance as a core capability, and publish clinical and economic outcomes alongside their products. For manufacturers, investors, technology providers and health systems alike, the coming decade offers a durable, regulation-driven growth platform.